Quantcast

Latest autoimmune diseases Stories

2014-06-03 08:32:05

SAN DIEGO, June 3, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today the initiation of dosing in an investigational Phase 1b clinical trial of APD334, a novel, oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P(1)) receptor, to evaluate the compound for the treatment of a number of autoimmune diseases. This randomized, double-blind and placebo-controlled Phase 1b trial will evaluate the safety, tolerability and pharmacokinetics...

2014-05-29 23:19:59

The 2014 LDN at the MEET is being organised by the charity the LDN Research Trust in the UK and Mark’s Dugs in the US. The conference reviews, compares and contrasts the most recent data and treatments for a variety of Auto-Immune and Immuno-modulated Conditions. (PRWEB) May 29, 2014 International conference to raise awareness about a ground-breaking drug. Physicians, patients and experts from all over the world will gather in Las Vegas this November at a major conference to discuss and...

2014-05-29 16:26:50

Snap a "Selfie" and Become a Part of Our Next Awareness Campaign DANVERS, Mass., May 29, 2014 /PRNewswire-USNewswire/ -- Too many people in the United States know nothing about scleroderma, a mysterious and frequently disabling condition, which affects an estimated 300,000 people, so this June the Scleroderma Foundation wants to increase awareness of the disease that can strip away a person's independence and quality of life. Scleroderma strikes women 4-to-1 over men, with the onset...

2014-05-29 16:26:10

VANCOUVER, May 29, 2014 /PRNewswire/ - Augurex Life Sciences Corp. announces a ground-breaking body of new data that will publish during the European League Against Rheumatism (EULAR) Annual Congress of Rheumatology taking place June 11-14 in Paris. Investigators will present the studies listed in the schedule below, which to date along with other publications, represent over 2000 patients evaluated with the 14-3-3 eta blood test. This follows the very recent publication of a study...

2014-05-29 08:29:17

RALEIGH, N.C., May 29, 2014 /PRNewswire/ -- Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing novel technologies for the diagnosis and treatment of metabolic disease, announced today the appointment of Steven Delmar, CPA, as Chief Financial Officer. Mr. Delmar brings more than 35 years of financial and operational executive leadership experience to the company, serving most recently as Director of Business Operations at Computer Sciences Corporation (CSC)....

2014-05-28 16:27:04

ROME, May 28, 2014 /PRNewswire/ -- Sigma-Tau announces that Synacthen (R) (tetracosactide hexa-acetate salt) is now available again in most of the European countries. (Logo: http://photos.prnewswire.com/prnh/20140528/689733 ) Manufacturing challenges connected to tetracosactide over the past months caused the shortage of -Synacthen(R)- for patients throughout Europe and Sigma-Tau has devoted all its efforts in reestablishing the supply chain into these...

2014-05-26 11:13:00

UT Southwestern Medical Center A microRNA cluster believed to be important for suppressing colon cancer has been found to play a critical role in wound healing in the intestine, UT Southwestern cancer researchers have found. The findings, first discovered in mice and later reproduced in human cells, could provide a fresh avenue for investigating chronic digestive diseases and for potentially repairing damage in these and other disease or injury settings. "We identified a novel role...

2014-05-22 12:26:37

LONDON, May 22, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Frontier Pharma: Systemic Lupus Erythematosus - Identifying and Commercializing First-in-Class Innovationhttp://www.reportbuyer.com/pharma_healthcare/diseases/frontier_pharma_systemic_lupus_erythematosus_identifying_commercializing_first_in_class_innovation.html Frontier Pharma: Systemic Lupus Erythematosus - Identifying and Commercializing First-in-Class Innovation SummaryThe Systemic Lupus...

2014-05-21 23:08:04

ReportsnReports.com adds “Crohn’s Disease Drug Market and Pipeline Analysis” report to its research store. Dallas, Texas (PRWEB) May 21, 2014 Under the umbrella of inflammatory bowel diseases, Crohn’s disease and ulcerative colitis are two most common disorders. Though both these disorders have similar symptoms, the difference arises in the areas affected in the gastrointestinal tract (GI tract). The Crohn’s disease in most cases affects the end of the small bowel (the ileum)...

2014-05-21 08:28:10

Tribute raises critically needed funds to support the Lupus Foundation of America's mission WASHINGTON, May 21, 2014 /PRNewswire-USNewswire/ -- Federal agency leaders, Members of Congress and national leaders from the chronic disease and disability communities gathered to pay Special Tribute to The Honorable Tom Harkin (D-IA), an unparalleled champion during his 30 years of public service for those affected by chronic disease and disability. The Tribute, held in Washington, DC on...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related